Skip to main content

Table 1 Characteristics of primary R5 viruses and Env clones

From: Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS

Virusa

Descriptionb

Env clonec

Coreceptor usaged

   

CCR5

CXCR4

Cross-sectional viruses

   

-

NB23

PA-R5

NB23-C1

+++

-

  

NB23-C2

+++

-

  

NB23-C3

+++

-

NB24

PA-R5

NB24-C1

++

-

  

NB24-C2

+

-

  

NB24-C3

+

-

  

NB24-C4

+

-

NB25

PA-R5

NB25-C1

+

-

  

NB25-C2

+

-

  

NB25-C3

+++

-

NB27

PA-R5

NB27-C1

+

-

  

NB27-C2

++

-

  

NB27-C3

+++

-

NB2

A-R5

NB2-C1

+

-

  

NB2-C2

+

-

  

NB2-C3

++

-

  

NB2-C4

++

-

NB6

A-R5

NB6-C1

+++

-

  

NB6-C2

+++

-

  

NB6-C3

+++

-

  

NB6-C4

+++

-

NB7

A-R5

NB7-C1

++

-

  

NB7-C2

++

-

  

NB7-C3

++

-

  

NB7-C4

++

-

NB8

A-R5

NB8-C1

+++

-

  

NB8-C2

+++

-

  

NB8-C3

+++

-

  

NB8-C4

+++

-

Longitudinal viruses

    

IK1-PA

PA-R5

IK1-PA-C1

++

-

  

IK1-PA-C2

+

-

  

IK1-PA-C3

++

-

  

IK1-PA-C4

+

-

IK1-A

A-R5

IK1-A-C1

++

-

  

IK1-A-C2

+++

-

  

IK1-A-C3

++

-

  

IK1-A-C4

++

-

Controls

    
  

ΔKS Env

-

-

  

HXB2 Env

-

+++

  

ADA Env

+++

-

  

89.6 Env

+++

+++

  1. aThe phenotypes of the primary R5 HIV-1 isolates, and clinical characteristics of the subjects from whom they were isolated have been described in detail previously [11, 13, 34, 36, 42].
  2. bPA-R5, pre-AIDS R5 HIV-1 isolate; A-R5, AIDS R5 HIV-1 isolate.
  3. cFunctional Env clones were identified by infection of JC53 cells or Cf2-CD4/CCR5/CXCR4 cells with Env-pseudotyped GFP reporter viruses and by fusion assays, as described in the Methods (data not shown).
  4. dCoreceptor usage of functional Envs was determined by infection of Cf2-CD4/CCR5 and Cf2-CD4/CXCR4 cell lines with Env-pseudotyped GFP-reporter viruses, as described in the Methods. GFP positive cells were counted manually by fluorescence microscopy and scored as – (no GFP positive cells), +/- (1 to 5% GFP positive cells), + (5 to 10% GFP positive cells), ++ (10 to 30% GFP positive cells), or +++ (>30% GFP positive cells).